We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

SemBioSys Completes pre-IND Meeting with U.S. FDA for APO AIMilano

News   Aug 12, 2009

 
SemBioSys Completes pre-IND Meeting with U.S. FDA for APO AIMilano
 
 
 

RELATED ARTICLES

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

Scientists Develop New Drug Treatment for TB

News

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound –developed after 10 years of painstaking research will be trialed on humans within three to four years.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE